Options for individualizing therapy for postoperative central diabetes insipidus
Larisa K. Dzeranova,
Darya S. Mikaylova,
Ekaterina A. Pigarova, 
Natalia G. Mokrysheva,
Lyudmila Y. Rozhinskaya,
Andrey Yu. Grigoriev,
Oksana V. Ivashchenko
Natalia G. Mokrysheva,
Lyudmila Y. Rozhinskaya,
Andrey Yu. Grigoriev,
Oksana V. Ivashchenko https://doi.org/10.14341/omet2017354-57
Abstract
Postoperative diabetes insipidus is a common life-threatening morbidity after pituitary surgery. More frequent neurosurgeon interventions make drugs’ adjustment very important for higher life quality in the case of postoperative complications. We present the case of personalized adjustment of drug dosage to treat postoperative diabetes insipidus in patient undergoing reccurent transnasal adenomectomy.
About the Authors
Larisa K. DzeranovaEndocrinology Research Centre
Russian Federation
Sc.D.
Darya S. Mikaylova
Endocrinology Research Centre
Russian Federation
postgraduate student
Ekaterina A. Pigarova
Endocrinology Research Centre
Russian Federation
PhD
Natalia G. Mokrysheva
Endocrinology Research Centre
Russian Federation
Sc.D., prof.
Lyudmila Y. Rozhinskaya
Endocrinology Research Centre
Russian Federation
Sc.D., prof.
Andrey Yu. Grigoriev
Endocrinology Research Centre
Russian Federation
Sc.D., prof.
Oksana V. Ivashchenko
Endocrinology Research Centre
Russian Federation
MD
References
1. Cook D, Yuen K, Biller B, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Growth Hormone Use in Growth Hormone-Deficient Adults and Transition Patients – 2009 Update. Endocr Pract. 2009;15(Supplement 2):1-29. doi: 10.4158/ep.15.s2.1.
2. Иловайская И.А. Диагностика и лечение гипопитуитаризма. В кн: Клиническая нейроэндокринология. / Под ред. И.И. Дедова. – М.: УП «Принт»; 2011. – С. 220–238 [Ilovayskaya IA. Diagnostika i lechenie gipopituitarizma In: Klinicheskaya neyroendokrinologiya. Dedov II, editor. Moscow: UP «Print»; 2011. p. 220-238. (In Russ)]
3. Мазеркина Н.А.. Минирин для сублингвального применения в терапии несахарного диабета у больных после хирургического лечения опухолей мозга // Проблемы Эндокринологии. – 2012. – Т. 58. – №5. – C. 46-49. [Mazerkina NA. Minirin for the sublingual application to manage diabetes insipidus in the patients treated for brain tumours. Problems of Endocrinology. 2012;58(5):46-49. (In Russ)] doi: 10.14341/probl201258546-49
4. Пигарова Е.А. Заболевания нейрогипофиза. В кн: Клиническая нейроэндокринология. / Под ред. И.И. Дедова. – М.: УП «Принт»; 2011. – С. 239–256. [Pigarova EA. Zabolevaniya neyrogipofiza. In: Klinicheskaya neyroendokrinologiya. Dedov II, editor. Moscow: UP «Print»; 2011. p. 239–256. (In Russ)]
5. Пигарова Е.А, Дзеранова Л.К, Рожинская Л.Я: Индивидуализация терапии центрального несахарного диабета: клинический случай применения препарата «Пресайнекс» // Ожирение и метаболизм. – 2010. – Т. 7. – №3. – C. 39-41. [Pigarova EA, Dzeranova LK, Rozhinskaya LY. Individualizatsiya terapii tsentral'nogo nesakharnogo diabeta: klinicheskiy sluchay primeneniya preparata «Presayneks». Obesity and metabolism. 2010;7(3):39-41. (In Russ)] doi: 10.14341/2071-8713-4983
6. Пигарова Е.А., Дзеранова Л.К., Рожинская Л.Я. Клинический случай применения пресайнекса у пациента с центральным несахарным диабетом вследствие гистиоцитоза Лангерганса //Эффективная фармакотерапия. – 2011. – №. 46. – С. 60-65. [Pigarova EA, Dzeranova LK, Rozhinskaya LYa. Klinicheskiy sluchay primeneniya Presayneksa u patsienta s tsentral'nym nesakharnym diabetom vsledstvie gistiotsitoza Langergansa. Effektivnaya farmakoterapiya. 2011;(46):60-65. (In Russ.)]
7. Пигарова Е.А., Дзеранова Л.К., Рожинская Л. Я. Клинический случай применения препарата пресайнекс у пациентки с центральным несахарным диабетом //Русский медицинский журнал. – 2011. – Т. 19. – №. 27. – C. 1714. [Pigarova EA, Dzeranova LK, Rozhinskaya LY. Klinicheskiy sluchay primeneniya preparata presayneks u patsientki s tsentral'nym nesakharnym diabetom. Russkiy meditsinskiy zhurnal. 2011;19(27):1714. (In Russ.)]
8. Справочник лекарств РЛС, 2000-2016 гг. Минирин® (Minirin) – инструкция по применению. Available from: http://www.rlsnet.ru/tn_index_id_16428.htm
9. Adams JR, Blevins LS, Allen GS, et al. Disorders of water metabolism following transsphenoidal pituitary surgery: A single institution’s experience. Pituitary. 2006;9(2):93-99. doi: 10.1007/s11102-006-9276-2.
10. Lamas C, del Pozo C, Villabona C. Guía clínica de manejo de la diabetes insípida y del síndrome de secreción inapropiada de hormona antidiurética en el postoperatorio de la cirugía hipofisaria. Endocrinología y Nutrición. 2014;61(4):e15-e24. doi: 10.1016/j.endonu.2014.01.005.
11. Loh JA, Verbalis JG. Diabetes insipidus as a complication after pituitary surgery. Nature Clinical Practice Endocrinology & Metabolism. 2007;3(6):489-494. doi: 10.1038/ncpendmet0513.
12. Nemergut EC, Dumont AS, Barry UT, Laws ER. Perioperative Management of Patients Undergoing Transsphenoidal Pituitary Surgery. Anesth Analg. 2005;101(4):1170-1181. doi: 10.1213/01.ane.0000166976.61650.ae.
13. Seckl J, Dunger D. Postoperative diabetes insipidus. BMJ. 1989;298(6665):2-3. doi: 10.1136/bmj.298.6665.2.
14. Sigounas DG, Sharpless JL, Cheng DML, et al. Predictors and Incidence of Central Diabetes Insipidus after Endoscopic Pituitary Surgery. Neurosurgery. 2008;62(1):71-79. doi: 10.1227/01.neu.0000311063.10745.d8.
15. Verbalis JG. Management of disorders of water metabolism in patients with pituitary tumors. Pituitary. 2002;5(2):119-132. doi: 10.1023/a:1022368615879.
Review
For citations:
Dzeranova L.K., Mikaylova D.S., Pigarova E.A., Mokrysheva N.G., Rozhinskaya L.Y., Grigoriev A.Yu., Ivashchenko O.V. Options for individualizing therapy for postoperative central diabetes insipidus. Obesity and metabolism. 2017;14(3):54-57. (In Russ.) https://doi.org/10.14341/omet2017354-57
Views:
2590
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
